Skip to content

Research at St Andrews

Improving quality of life through the routine use of the patient concerns inventory for head and neck cancer patients: a cluster preference randomized controlled trial

Research output: Contribution to journalArticle

Standard

Improving quality of life through the routine use of the patient concerns inventory for head and neck cancer patients : a cluster preference randomized controlled trial. / Rogers, Simon N.; Lowe, Derek; Lowies, Cher; Yeo, Seow Tien; Allmark, Christine; Mcavery, Dominic; Humphris, Gerald M.; Flavel, Robert; Semple, Cherith; Thomas, Steven J.; Kanatas, Anastasios.

In: BMC Cancer, Vol. 18, 444, 18.04.2018.

Research output: Contribution to journalArticle

Harvard

Rogers, SN, Lowe, D, Lowies, C, Yeo, ST, Allmark, C, Mcavery, D, Humphris, GM, Flavel, R, Semple, C, Thomas, SJ & Kanatas, A 2018, 'Improving quality of life through the routine use of the patient concerns inventory for head and neck cancer patients: a cluster preference randomized controlled trial' BMC Cancer, vol. 18, 444. https://doi.org/10.1186/s12885-018-4355-0

APA

Rogers, S. N., Lowe, D., Lowies, C., Yeo, S. T., Allmark, C., Mcavery, D., ... Kanatas, A. (2018). Improving quality of life through the routine use of the patient concerns inventory for head and neck cancer patients: a cluster preference randomized controlled trial. BMC Cancer, 18, [444]. https://doi.org/10.1186/s12885-018-4355-0

Vancouver

Rogers SN, Lowe D, Lowies C, Yeo ST, Allmark C, Mcavery D et al. Improving quality of life through the routine use of the patient concerns inventory for head and neck cancer patients: a cluster preference randomized controlled trial. BMC Cancer. 2018 Apr 18;18. 444. https://doi.org/10.1186/s12885-018-4355-0

Author

Rogers, Simon N. ; Lowe, Derek ; Lowies, Cher ; Yeo, Seow Tien ; Allmark, Christine ; Mcavery, Dominic ; Humphris, Gerald M. ; Flavel, Robert ; Semple, Cherith ; Thomas, Steven J. ; Kanatas, Anastasios. / Improving quality of life through the routine use of the patient concerns inventory for head and neck cancer patients : a cluster preference randomized controlled trial. In: BMC Cancer. 2018 ; Vol. 18.

Bibtex - Download

@article{86c231797cb54c0ebd9a3b98de4c0ef6,
title = "Improving quality of life through the routine use of the patient concerns inventory for head and neck cancer patients: a cluster preference randomized controlled trial",
abstract = "Background: The consequences of treatment for Head and Neck cancer (HNC) patients has profound detrimental impacts such as impaired QOL, emotional distress, delayed recovery and frequent use of healthcare. The aim of this trial is to determine if the routine use of the Patients Concerns Inventory (PCI) package in review clinics during the first year following treatment can improve overall quality of life, reduce the social-emotional impact of cancer and reduce levels of distress. Furthermore, we aim to describe the economic costs and benefits of using the PCI.Methods: This will be a cluster preference randomised control trial with consultants either ‘using’ or ‘not using’ the PCI package at clinic. It will involve two centres Leeds and Liverpool. 416 eligible patients from at least 10 consultant clusters are required to show a clinically meaningful difference in the primary outcome. The primary outcome is the percentage of participants with less than good overall quality of life at the final one-year clinic as measured by the University of Washington QOL questionnaire version 4 (UWQOLv4). Secondary outcomes at one-year are the mean social-emotional subscale (UWQOLv4) score, Distress Thermometer (DT) score ≥ 4, and key health economic measures (QALY-EQ-5D-5 L; CSRI).Discussion: This trial will provide knowledge on the effectiveness of a consultation intervention package based around the PCI used at routine follow-up clinics following treatment of head and neck cancer with curative intent. If this intervention is (cost) effective for patients, the next step will be to promote wider use of this approach as standard care in clinical practice.Trial registration: 32,382. Clinical Trials Identifier, NCT03086629. Protocol: Version 3.0, 1st July 2017.",
keywords = "Head and neck cancer, Patient concerns inventory, Quality of life, Patient reported outcomes, Intervention",
author = "Rogers, {Simon N.} and Derek Lowe and Cher Lowies and Yeo, {Seow Tien} and Christine Allmark and Dominic Mcavery and Humphris, {Gerald M.} and Robert Flavel and Cherith Semple and Thomas, {Steven J.} and Anastasios Kanatas",
note = "This trial is funded by the RfPB on behalf of the NIHR (PB-PG-0215-36047).",
year = "2018",
month = "4",
day = "18",
doi = "10.1186/s12885-018-4355-0",
language = "English",
volume = "18",
journal = "BMC Cancer",
issn = "1471-2407",
publisher = "BioMed Central",

}

RIS (suitable for import to EndNote) - Download

TY - JOUR

T1 - Improving quality of life through the routine use of the patient concerns inventory for head and neck cancer patients

T2 - BMC Cancer

AU - Rogers, Simon N.

AU - Lowe, Derek

AU - Lowies, Cher

AU - Yeo, Seow Tien

AU - Allmark, Christine

AU - Mcavery, Dominic

AU - Humphris, Gerald M.

AU - Flavel, Robert

AU - Semple, Cherith

AU - Thomas, Steven J.

AU - Kanatas, Anastasios

N1 - This trial is funded by the RfPB on behalf of the NIHR (PB-PG-0215-36047).

PY - 2018/4/18

Y1 - 2018/4/18

N2 - Background: The consequences of treatment for Head and Neck cancer (HNC) patients has profound detrimental impacts such as impaired QOL, emotional distress, delayed recovery and frequent use of healthcare. The aim of this trial is to determine if the routine use of the Patients Concerns Inventory (PCI) package in review clinics during the first year following treatment can improve overall quality of life, reduce the social-emotional impact of cancer and reduce levels of distress. Furthermore, we aim to describe the economic costs and benefits of using the PCI.Methods: This will be a cluster preference randomised control trial with consultants either ‘using’ or ‘not using’ the PCI package at clinic. It will involve two centres Leeds and Liverpool. 416 eligible patients from at least 10 consultant clusters are required to show a clinically meaningful difference in the primary outcome. The primary outcome is the percentage of participants with less than good overall quality of life at the final one-year clinic as measured by the University of Washington QOL questionnaire version 4 (UWQOLv4). Secondary outcomes at one-year are the mean social-emotional subscale (UWQOLv4) score, Distress Thermometer (DT) score ≥ 4, and key health economic measures (QALY-EQ-5D-5 L; CSRI).Discussion: This trial will provide knowledge on the effectiveness of a consultation intervention package based around the PCI used at routine follow-up clinics following treatment of head and neck cancer with curative intent. If this intervention is (cost) effective for patients, the next step will be to promote wider use of this approach as standard care in clinical practice.Trial registration: 32,382. Clinical Trials Identifier, NCT03086629. Protocol: Version 3.0, 1st July 2017.

AB - Background: The consequences of treatment for Head and Neck cancer (HNC) patients has profound detrimental impacts such as impaired QOL, emotional distress, delayed recovery and frequent use of healthcare. The aim of this trial is to determine if the routine use of the Patients Concerns Inventory (PCI) package in review clinics during the first year following treatment can improve overall quality of life, reduce the social-emotional impact of cancer and reduce levels of distress. Furthermore, we aim to describe the economic costs and benefits of using the PCI.Methods: This will be a cluster preference randomised control trial with consultants either ‘using’ or ‘not using’ the PCI package at clinic. It will involve two centres Leeds and Liverpool. 416 eligible patients from at least 10 consultant clusters are required to show a clinically meaningful difference in the primary outcome. The primary outcome is the percentage of participants with less than good overall quality of life at the final one-year clinic as measured by the University of Washington QOL questionnaire version 4 (UWQOLv4). Secondary outcomes at one-year are the mean social-emotional subscale (UWQOLv4) score, Distress Thermometer (DT) score ≥ 4, and key health economic measures (QALY-EQ-5D-5 L; CSRI).Discussion: This trial will provide knowledge on the effectiveness of a consultation intervention package based around the PCI used at routine follow-up clinics following treatment of head and neck cancer with curative intent. If this intervention is (cost) effective for patients, the next step will be to promote wider use of this approach as standard care in clinical practice.Trial registration: 32,382. Clinical Trials Identifier, NCT03086629. Protocol: Version 3.0, 1st July 2017.

KW - Head and neck cancer

KW - Patient concerns inventory

KW - Quality of life

KW - Patient reported outcomes

KW - Intervention

U2 - 10.1186/s12885-018-4355-0

DO - 10.1186/s12885-018-4355-0

M3 - Article

VL - 18

JO - BMC Cancer

JF - BMC Cancer

SN - 1471-2407

M1 - 444

ER -

Related by author

  1. Dental anxiety, communication and the dental team: responses to fearful patients

    Freeman, R. & Humphris, G. M., Aug 2019, In : Journal of the California Dental Association. 47, 8, p. 495-500

    Research output: Contribution to journalArticle

  2. Psychometric properties of the Chinese version Fear of Cancer Recurrence Questionnaire-7 (FCR-7)

    Yang, Y., Humphris, G., Sun, H., Li, W., Hao, Y., Liu, T., Zhang, J., Wang, H. & Zhang, B., 25 Jul 2019, In : Professional Psychology: Research and Practice. Online First

    Research output: Contribution to journalArticle

  3. Automated screening for distress: a perspective for the future

    Rana, R., Latif, S., Gururajan, R., Gray, A., Mackenzie, G., Humphris, G. & Dunn, J., 18 Jul 2019, In : European Journal of Cancer Care. 28, 4, e13033.

    Research output: Contribution to journalArticle

  4. Prevalence and clinical and psychological correlates of high fear of cancer recurrence in patients newly diagnosed with head and neck cancer

    Mirosevic, S., Thewes, B., van Herpen, C., Kaanders, J., Merkx, T., Humphris, G., Baatenburg de Jong, R. J., Langendijk, J. A., Leemans, C. R., Terhaard, C. H. J., Verdonck-de Leeuw, I. M., Takes, R., Prins, J. & NET-QUBIC Consortium, 7 Jun 2019, In : Head and Neck. Early View, 14 p.

    Research output: Contribution to journalArticle

Related by journal

  1. Fear of cancer recurrence trajectory during radiation treatment and follow-up into survivorship of patients with breast cancer

    Yang, Y., Cameron, J., Bedi, C. & Humphris, G., 20 Oct 2018, In : BMC Cancer. 18, 9 p., 1002.

    Research output: Contribution to journalArticle

  2. Serum and blood based biomarkers for lung cancer screening: a systematic review

    Chu, G. C. W., Lazare, K. & Sullivan, F., 13 Feb 2018, In : BMC Cancer. 18, 6 p., 181.

    Research output: Contribution to journalReview article

  3. A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma

    Gremel, G., Djureinovic, D., Niinivirta, M., Laird, A., Ljungqvist, O., Johannesson, H., Bergman, J., Edqvist, P-H., Navani, S., Khan, N., Patil, T., Sivertsson, Å., Uhlén, M., Harrison, D. J., Ullenhag, G. J., Stewart, G. D. & Pontén, F., 4 Jan 2017, In : BMC Cancer. 17, 9 p., 9.

    Research output: Contribution to journalArticle

ID: 252871125